Discontinued — last reported Q3 '25
Edison International Equity Method Investments decreased by 1.4% to $4.52B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.4%, from $4.29B to $4.52B. Over 2 years (FY 2023 to FY 2025), Equity Method Investments shows relatively stable performance with a 4.2% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.23B | $4.35B | $4.36B | $4.47B | $4.34B | $4.29B | $4.39B | $4.55B | $4.59B | $4.52B |
| QoQ Change | — | +2.9% | +0.3% | +2.5% | -2.9% | -1.2% | +2.3% | +3.6% | +0.9% | -1.4% |
| YoY Change | — | — | — | — | +2.7% | -1.4% | +0.6% | +1.6% | +5.6% | +5.4% |